v3.25.3

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Income Statement [Abstract]
NET REVENUE	$ 1,435,016	$ 1,278,546	$ 4,184,073	$ 3,651,784
COST OF REVENUE	1,162,114	1,021,797	3,379,076	2,907,170
GROSS PROFIT	272,902	256,749	804,997	744,614
OPERATING COSTS AND EXPENSES:
Selling, general and administrative expenses	172,104	156,999	510,314	465,524
Depreciation and amortization expense	16,291	14,659	48,278	44,294
Total operating expenses	188,395	171,658	558,592	509,818
OPERATING INCOME	84,507	85,091	246,405	234,796
OTHER INCOME (EXPENSE):
Interest expense, net	(14,146)	(12,345)	(41,824)	(38,150)
Equity in earnings of joint ventures	2,176	1,391	5,300	3,921
Other, net	(3,570)	(583)	(8,497)	1,983
Total other (expense) income	(15,540)	(11,537)	(45,021)	(32,246)
INCOME BEFORE INCOME TAXES	68,967	73,554	201,384	202,550
INCOME TAX EXPENSE	17,151	19,698	52,303	50,860
NET INCOME	51,816	53,856	149,081	151,690
OTHER COMPREHENSIVE INCOME (LOSS), NET OF TAX:
Change in unrealized (loss) gain on cash flow hedges, net of income tax benefit of $478, $1,998, $1,809 and $1,785, respectively	(1,463)	(6,127)	(5,545)	(5,475)
OTHER COMPREHENSIVE (LOSS) INCOME	(1,463)	(6,127)	(5,545)	(5,475)
NET COMPREHENSIVE INCOME	$ 50,353	$ 47,729	$ 143,536	$ 146,215
EARNINGS PER COMMON SHARE:
Earnings per share, basic (in dollars per share)	$ 0.32	$ 0.32	$ 0.91	$ 0.88
Earnings per share, diluted (in dollars per share)	$ 0.32	$ 0.31	$ 0.91	$ 0.87
Weighted average common shares outstanding, basic (in shares)	161,829	170,636	163,393	172,490
Weighted average common shares outstanding, diluted (in shares)	163,086	171,941	164,602	173,848

Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(24))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(26))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(22))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1A
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1B
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(20))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-5

Option Care Health, Inc. 10-Q